RA
Ramtin Agah
Chief Medical OfficerDirector

Ramtin Agah insider trades: RenovoRx (RNXT) stock purchases

Chief Medical Officer, RenovoRx Last trade Jan 21, 2026 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$48K
Bought, last 12 months
5 buys
11
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ramtin reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 21, 2026RNXT↑ Buy$10K
Dec 30, 2025RNXT↑ Buy$169
Dec 16, 2025RNXT↑ Buy$10K
Dec 5, 2025RNXT↑ Buy$10K
Nov 24, 2025RNXT↑ Buy$18K
Jun 5, 2025RNXT↑ Buy$29K
Apr 15, 2025RNXT↑ Buy$14K
Apr 11, 2025RNXT↑ Buy$16K
Apr 9, 2025RNXT↑ Buy$24K
Apr 8, 2025RNXT↑ Buy$22K
Jun 7, 2022RNXT↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RNXT insiders

Open-market trades in the last 12 months

About Ramtin Agah's insider trades

Ramtin Agah is Chief Medical Officer at RenovoRx (RNXT). Since Jun 7, 2022, Ramtin has reported 11 open-market purchases worth $163K and no sales on SEC Form 4. In the last 12 months: 5 buys ($48K).

Their filings also include grants and awards (7 filings), gifts (2 filings), other transactions (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RNXT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.